Stents Drug Eluting

This channel includes news and new technology innovations for drug eluting stents (DES). These drug coated stents were developed to solve a frequent problem with bare metal stents, which can cause neointimal hyperplasia (scar tissue growth) in some patients. The antiproliferative drugs used on DES prevent the growth of tissue. One downside of DES is the requirement for patients to take long-term antiplatelet therapy to prevent the possible formation of clots on these stents. Newer generation DES use technologies help the vessels heal faster, which may allow reduce the duration of dual antiplatelet therapy (DAPT), or use a single drug, usually eliminating aspirin. This section includes news for both metallic and bioresorbable drug-eluting stents and related clinical trial data.

News | September 07, 2010

September 7, 2010 – New analyses of subgroups from the SORT OUT III study provide detail on longer-term...

News | September 01, 2010

September 1, 2010 - The results of follow-up tests undertaken ten years after the first patient was treated with a...

News | September 01, 2010

September 1, 2010 - A new zotarolimus-eluting coronary stent using a biocompatible polymer gained CE mark...

The Genous R-Stent uses a prohealing surface utilizing endothelial progenitor cell (EPC) capture technology to aid rapid stent endothelialization. Photo copyright OrbusNeich

Feature | August 26, 2010 | David Smith, M.D.

In the world of endovascular devices, the rule is no longer one size fits all. The recent increase in the...

News | August 24, 2010

August 24, 2010 – Optical coherence tomography (OCT) evaluation of a patient with anterior ST-elevation myocardial...

News | August 20, 2010

August 19, 2010 – The Cardiovascular Research Foundation recently announced the late-breaking trials and...

News | August 03, 2010

August 3, 2010 — Patient enrollment began in the EVOLVE clinical trial, which is designed to assess the...

News | July 30, 2010

July 30, 2010 – A drug-eluting coronary bifurcation stent received CE mark this week for clinical use in...

News | June 11, 2010

June 11, 2010 – A new drug-eluting stent (DES) was launched this week in the European Union and other CE...

News | June 03, 2010

June 3, 2010 – Six-month data from the first 45 patients enrolled in the second stage of a trial for a bioresorbable...

News | May 27, 2010

May 27, 2010 – One-year data presented this week at EuroPCR in Paris confirms sustained clinical outcomes with Cook...

News | May 26, 2010

May 26, 2010 – In the constantly evolving battle for the best coronary stent, Boston Scientific said today it...

News | May 26, 2010

May 26, 2010 – The 12-month study results for a drug-eluting stent that uses hundreds of tiny holes, filled with...

Trial data shows the Resolute stent has a similar safety profile to Xience.

News | May 25, 2010

May 25, 2010 – The highly anticipated first results of the RESOLUTE All Comers study were presented today during the...

News | May 25, 2010

May 25, 2010 – A self-expanding, drug-eluting stent (DES) that just gained CE mark clearance in Europe is...

Overlay Init